Home > Insider Trading > Coherus Oncology Inc. > Profile

Coherus Oncology Inc. (CHRS)

Market is closed

Sector: Biological Products, (No Disgnostic Substances)

Insider Roster

Jill O'donnell-Tormey, 2025-06-13
Nisley Lee Newcomer, 2025-06-13
Mats Wahlstrom, 2025-06-13
Lee Michael Ryan, 2025-06-13
A Rita Karachun, 2025-06-13
Georgia Erbez, 2025-06-13
W. Charles Newton, 2025-06-13
J. Ali Satvat, 2025-06-13
J Bryan Mcmichael, Chief Financial Officer, 2025-05-09
M Dennis Lanfear, President & Ceo, 2025-05-09
Paul Reider, Chief Commercial Officer, 2025-01-23
Mark Stolper, 2024-06-05
Jo Kimberly Tzoumakas, 2024-06-05
Mcdavid Stilwell, Chief Financial Officer, 2024-01-03
Vladimir Vexler, Chief Scientific Officer, 2023-04-05
James Healy, Director, 2022-02-11
R Vincent Anicetti, Chief Operating Officer, 2021-07-08
C Alan Mendelson, Director, 2021-05-25
Jean-Frederic Viret, Chief Financial Officer, 2021-02-03
T Mary Szela, Director, 2021-01-13
Md R Samuel Nussbaum, Director, 2021-01-13
Bryan V Lawlis, Director, 2021-01-13
Christos Richards, Director, 2020-01-14
Ltd Pte Investments V-Sciences, Large Shareholder, 2020-01-08
Ltd Private Sciences Life Temasek, Large Shareholder, 2020-01-08
Ltd Pte Management Fullerton, Large Shareholder, 2020-01-08
Ltd (Private) Holdings Temasek, Large Shareholder, 2020-01-08
P Darlene Horton, See Remarks, 2019-01-23
K Barbara Finck, Chief Medical Officer, 2018-09-12
K. Peter Watler, Chief Technical Officer, 2018-02-05
J. August Troendle, Director, 2018-02-05
C. Alan Herman, Chief Scientific Officer, 2017-12-19
Fmr Llc, Other, 2016-08-10
L.p. Biosimilar Kkr, Large Shareholder, 2014-11-14
R Henry Kravis, Large Shareholder, 2014-11-14
R George Roberts, Large Shareholder, 2014-11-14
Kkr & Co. L.p., Large Shareholder, 2014-11-14
Kkr Management Llc, Large Shareholder, 2014-11-14
Ltd Group Kkr, Large Shareholder, 2014-11-14
L.p. Holdings Group Kkr, Large Shareholder, 2014-11-14
Ltd Gp Holdings Fund Kkr, Large Shareholder, 2014-11-14
L.p. Holdings Fund Kkr, Large Shareholder, 2014-11-14
Kkr Biosimilar Gp Llc, Large Shareholder, 2014-11-14
Daiichi Sankyo Company, Ltd, Other, 2014-11-12
Lilly Eli & Co, Other, 2014-11-12
Lilly Ventures Fund I Llc, Other, 2014-11-12

Show All Insiders (46)

Hedge Fund Popularity

Display

Display Share Price

Display Large Version

Hedge Fund Holdings

Filing Period:

Last updated on November 19, 2025, 12:48pm based on SEC 13F filings Last update: November 19, 2025, 12:48pm

No.	Hedge Fund	Shares	Value	Activity	% Port
1.	Tang Capital Management Kevin C. Tang	5,097,362	$8,359,674		0.32%
2.	AQR Capital Management Cliff Asness	903,037	$1,480,981	+18%	0%
3.	Hudson Bay Capital Management Sander Gerber	810,000	$1,328,400	-3%	0%
4.	Citadel Investment Group Ken Griffin	331,155	$543,094	+148%	0%
5.	Leucadia National Ian Cumming And Joseph Steinberg	325,625	$534,025	+3%	0%

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Stilwell Officer	$13.42	3,700	$49,667.69	35,118	2021-06-09	Filing
Healy Director	$13.50	425,926	$5,750,001.00	2,557,759	2014-11-12	Filing
Lilly Other	$13.50	164,963	$2,227,000.50	3,042,019	2014-11-12	Filing

Insider Trading: Sales See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Wahlstrom	$0.74	99,988	$73,881.13	0	2025-05-23	Filing
Lanfear	$2.02	223,100	$449,769.60	731,693	2023-11-22	Filing
Stilwell Officer	$16.80	3,507	$58,918.65	31,611	2021-10-15	Filing
Healy Director	$16.12	286,076	$4,611,545.12	0	2021-09-29	Filing
Healy Director	$17.17	48,329	$829,808.93	286,076	2021-09-28	Filing

Institutional Investors' Holdings

Filing Period:

No.	Name	Shares	Value	% Port
1.	Blackrock, Inc.	10,459,986	$17,154,377	0%
2.	Vanguard Group Inc	10,321,107	$16,926,616	0%
3.	Kohlberg Kravis Roberts & Co. L.p.	3,036,076	$4,931,401	0.08%
4.	Geode Capital Management, Llc	2,741,226	$4,496,453	0%
5.	State Street Corp	2,223,376	$3,646,337	0%

News See All

Click here to See All News